Skip to main content

clinical trials

By Anthony Vecchione | 03:36 pm | May 27, 2025
The company will use the funds to grow its team, expedite commercial deployments with pharma companies and enhance Willis, its new clinical outcome assessment platform.  
By Jessica Hagen | 03:10 pm | May 13, 2025
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
By Anthony Vecchione | 03:22 pm | May 05, 2025
Via Datavant's data utility and privacy platform, Boehringer Ingelheim can evaluate data and streamline data discovery.  
By Anthony Vecchione | 02:42 pm | April 08, 2025
The alliance allows Flatiron Health to use Massive Bio's database to match oncology patients to clinical trials within their proximity.    
By Nathan Eddy | 12:54 pm | March 05, 2025
The partners aim to streamline clinical trials by automating data transfer from electronic health records to trial databases to reduce administrative burdens and accelerate research.
By Anthony Vecchione | 02:03 pm | January 23, 2025
The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.
By HIMSS TV | 07:00 am | August 30, 2024
QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.
HIMSS23
By HIMSS TV | 07:15 pm | April 13, 2023
Dr. Laura Jehi, the health system's chief research information officer, discusses how the Epic EHR and MyChart are helping recruit participants for research initiatives such as the Cleveland Clinic BioRepository.
HIMSS21
By HIMSS TV | 01:35 am | October 19, 2021
The long view for digital health as it relates to clinical trials is implementing innovative tools and processes that make sense for the patient, says Dr. Joy Bhosai, cofounder and CEO of Pluto Health.
HIMSS21
By HIMSS TV | 08:05 am | September 07, 2021
Chris Boone, global head of health economics and outcomes research at AbbVie, shares why pharmaceutical companies are still working to improve diversity in clinical trials.

MobiHealthNews